Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Immune-surveillance on the Development of Colorectal Cancer in Patients With Lynch Syndrome

NCT06708429 is registered in ClinicalTrials.gov with San Raffaele University as lead sponsor.

NCT NCT06708429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06708429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Immune-surveillance on the Development of Colorectal Cancer in Patients With Lynch Syndrome
Lead sponsor
San Raffaele University
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2023
Completion date
June 1, 2034
Enrollment
300 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary cancer, hereditary cancer syndrome, hnpcc, hnpcc gene mutation, lynch syndrome, lynch syndrome i, lynch syndrome i (site-specific colonic cancer), lynch syndrome ii, mlh1 gene deletion+duplication, mlh1 gene inactivation, mlh1 gene mutation, mlh1 loss of expression, msh2 gene deletion+duplication, msh2 gene inactivation, msh2 gene mutation, msh2 loss of expression, msh6 gene inactivation, msh6 gene mutation, msh6 loss of expression, pms2 gene inactivation, pms2 gene mutation, pms2 loss of expression